CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockadeYuji Sato(Waseda University), Vivek Arora(Bristol-Myers Squibb (Germany))JCI InsightDecember 5, 201810.1172/jci.insight.121062Cited by 55SaveCiteExport RISWatch citationsRelated PapersOrganoid Cultures Derived from Patients with Advanced Prostate Cancer|Cell|2014|1.6kBladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation|eLife|2017|81